Imperative Care valuation, funding and investors

Imperative Care works in medical technology manufacturing, based in Campbell, United States. Founded in 2015, it has about 421 employees.

Medical Supply Manufacturers Debt

VALUATION · TODAY

$2.63B −18% after Series E

Range $1.00B – $4.00B · Grade C

TODAY

+12 MO

$2.00B

$4.00B

$6.00B

2016

2017

2018

2019

2020

2021

2022

2023

2024

2025

2026

2027

Series C $85.0M

Series D $260M

Series E $150M

ValuationBefore first round12-month outlook: where it points, how wide it fansHover the past: the outlook shows what was predicted then

HEADCOUNT · TODAY421 employees

+7%6m growth

+23%1y growth

+40%2y growth

250

500

Data from Jan 2021

TODAY

Predicted in 1 yr $2.15B −18% vs today

Predicted next raise $289M if a round comes

Winding-down probability 0%

Last round: Series E · $150M · Jul 2024
Valuation at last round: $1.88B · implied
Headcount: 421 · up
Grade: C
Founded: 2015

How VCMC values companies →

Imperative Care valuation today

VCMC values Imperative Care at $2.6B today, with a range of $1.0B to $4.0B and a grade of C. The valuation starts from its last funding round, a Series E round in Jul 2024.

Valuation by date (146 rows)

Each point is what the model would have shown on that date, using only what was known then; before its first round, a company is valued as a startup because it later raised.

Imperative Care: valuation by date, as the model would have shown it on each date
Date	Valuation	Range	Predicted in 1 yr	Phase	Headcount	Trend	Grade	Winding-down probability
1 Jan 2015	$5.25M	$1.91M – $14.4M	$5.51M (+5%)	before first round	–	unknown	D	0%
1 Feb 2015	$5.28M	$1.92M – $14.5M	$5.53M (+5%)	before first round	–	unknown	D	0%
1 Mar 2015	$5.29M	$1.93M – $14.5M	$5.55M (+5%)	before first round	–	unknown	D	0%
1 Apr 2015	$5.32M	$1.93M – $14.6M	$5.57M (+5%)	before first round	–	unknown	D	0%
1 May 2015	$5.34M	$1.94M – $14.7M	$5.59M (+5%)	before first round	–	unknown	D	0%
1 Jun 2015	$5.36M	$1.95M – $14.7M	$5.61M (+5%)	before first round	–	unknown	D	0%
1 Jul 2015	$5.38M	$1.96M – $14.8M	$5.64M (+5%)	before first round	–	unknown	D	0%
1 Aug 2015	$5.40M	$1.97M – $14.8M	$5.78M (+7%)	before first round	–	unknown	D	0%
1 Sep 2015	$5.42M	$1.97M – $14.9M	$5.94M (+10%)	before first round	–	unknown	D	0%
1 Oct 2015	$5.44M	$1.98M – $14.9M	$6.09M (+12%)	before first round	–	unknown	D	0%
1 Nov 2015	$5.46M	$1.99M – $15.0M	$6.26M (+15%)	before first round	–	unknown	D	0%
1 Dec 2015	$5.48M	$2.00M – $15.1M	$6.42M (+17%)	before first round	–	unknown	D	0%
1 Jan 2016	$5.51M	$2.00M – $15.1M	$6.60M (+20%)	before first round	–	unknown	D	0%
1 Feb 2016	$5.53M	$2.01M – $15.2M	$6.78M (+23%)	before first round	–	unknown	D	0%
1 Mar 2016	$5.55M	$2.02M – $15.2M	$6.95M (+25%)	before first round	–	unknown	D	0%
1 Apr 2016	$5.57M	$2.03M – $15.3M	$7.14M (+28%)	before first round	–	unknown	D	0%
1 May 2016	$5.59M	$2.04M – $15.4M	$7.33M (+31%)	before first round	–	unknown	D	0%
1 Jun 2016	$5.61M	$2.04M – $15.4M	$7.53M (+34%)	before first round	–	unknown	D	0%
1 Jul 2016	$5.64M	$2.05M – $15.5M	$7.72M (+37%)	before first round	–	unknown	D	0%
1 Aug 2016	$5.79M	$2.11M – $15.9M	$7.93M (+37%)	before first round	–	unknown	D	0%
1 Sep 2016	$5.94M	$2.16M – $16.3M	$8.15M (+37%)	before first round	–	unknown	D	0%
1 Oct 2016	$6.10M	$2.22M – $16.8M	$8.36M (+37%)	before first round	–	unknown	D	0%
1 Nov 2016	$6.26M	$2.28M – $17.2M	$8.59M (+37%)	before first round	–	unknown	D	0%
1 Dec 2016	$6.43M	$2.34M – $17.7M	$8.81M (+37%)	before first round	–	unknown	D	0%
1 Jan 2017	$6.60M	$2.40M – $18.1M	$9.05M (+37%)	before first round	–	unknown	D	0%
1 Feb 2017	$6.78M	$2.47M – $18.6M	$9.29M (+37%)	before first round	–	unknown	D	0%
1 Mar 2017	$6.94M	$2.53M – $19.1M	$9.52M (+37%)	before first round	–	unknown	D	0%
1 Apr 2017	$7.13M	$2.60M – $19.6M	$9.78M (+37%)	before first round	–	unknown	D	0%
1 May 2017	$7.32M	$2.67M – $20.1M	$10.0M (+37%)	before first round	–	unknown	D	0%
1 Jun 2017	$7.52M	$2.74M – $20.7M	$10.3M (+37%)	before first round	–	unknown	D	0%
1 Jul 2017	$7.72M	$2.81M – $21.2M	$10.6M (+37%)	before first round	–	unknown	D	0%
1 Aug 2017	$7.93M	$2.89M – $21.8M	$10.9M (+37%)	before first round	–	unknown	D	0%
1 Sep 2017	$8.14M	$2.96M – $22.4M	$11.2M (+37%)	before first round	–	unknown	D	0%
1 Oct 2017	$8.36M	$3.04M – $23.0M	$11.5M (+37%)	before first round	–	unknown	D	0%
1 Nov 2017	$8.58M	$3.12M – $23.6M	$11.8M (+37%)	before first round	–	unknown	D	0%
1 Dec 2017	$8.81M	$3.21M – $24.2M	$12.1M (+37%)	before first round	–	unknown	D	0%
1 Jan 2018	$9.05M	$3.29M – $24.9M	$12.4M (+37%)	before first round	–	unknown	D	0%
1 Feb 2018	$9.29M	$3.38M – $25.5M	$12.7M (+37%)	before first round	–	unknown	D	0%
1 Mar 2018	$9.52M	$3.47M – $26.2M	$13.1M (+37%)	before first round	–	unknown	D	0%
1 Apr 2018	$9.78M	$3.56M – $26.9M	$13.4M (+37%)	before first round	–	unknown	D	0%
1 May 2018	$10.0M	$3.65M – $27.6M	$13.8M (+37%)	before first round	–	unknown	D	0%
1 Jun 2018	$10.3M	$3.75M – $28.3M	$14.1M (+37%)	before first round	–	unknown	D	0%
1 Jul 2018	$10.6M	$3.85M – $29.1M	$14.5M (+37%)	before first round	–	unknown	D	0%
1 Aug 2018	$10.9M	$3.96M – $29.9M	$14.7M (+35%)	before first round	–	unknown	D	0%
1 Sep 2018	$11.2M	$4.06M – $30.7M	$14.8M (+32%)	before first round	–	unknown	D	0%
1 Oct 2018	$11.5M	$4.17M – $31.5M	$14.9M (+30%)	before first round	–	unknown	D	0%
1 Nov 2018	$11.8M	$4.28M – $32.3M	$15.1M (+28%)	before first round	–	unknown	D	0%
1 Dec 2018	$12.1M	$4.40M – $33.2M	$15.2M (+26%)	before first round	–	unknown	D	0%
1 Jan 2019	$12.4M	$4.52M – $34.1M	$15.3M (+24%)	before first round	–	unknown	D	0%
1 Feb 2019	$12.7M	$4.64M – $35.0M	$15.5M (+21%)	before first round	–	unknown	D	0%
1 Mar 2019	$13.1M	$4.75M – $35.9M	$15.6M (+19%)	before first round	–	unknown	D	0%
1 Apr 2019	$13.4M	$4.88M – $36.8M	$15.7M (+17%)	before first round	–	unknown	D	0%
1 May 2019	$13.8M	$5.01M – $37.8M	$15.9M (+15%)	before first round	–	unknown	D	0%
1 Jun 2019	$14.1M	$5.15M – $38.8M	$16.0M (+13%)	before first round	–	unknown	D	0%
1 Jul 2019	$14.5M	$5.28M – $39.8M	$16.2M (+11%)	before first round	–	unknown	D	0%
1 Aug 2019	$14.7M	$5.33M – $40.2M	$16.3M (+11%)	before first round	–	unknown	D	0%
1 Sep 2019	$14.8M	$5.38M – $40.6M	$16.5M (+11%)	before first round	–	unknown	D	0%
1 Oct 2019	$14.9M	$5.43M – $41.0M	$16.6M (+11%)	before first round	–	unknown	D	0%
1 Nov 2019	$15.1M	$5.48M – $41.4M	$16.8M (+11%)	before first round	–	unknown	D	0%
1 Dec 2019	$15.2M	$5.53M – $41.7M	$16.9M (+11%)	before first round	–	unknown	D	0%
11 Dec 2019	$773M	$508M – $1.5B	$1.0B (+30%)	after a round	–	unknown	B	0%
1 Jan 2020	$785M	$508M – $1.5B	$1.0B (+28%)	after a round	–	unknown	B	0%
1 Feb 2020	$803M	$508M – $1.5B	$1.0B (+25%)	after a round	–	unknown	B	0%
1 Mar 2020	$820M	$508M – $1.5B	$1.0B (+23%)	after a round	–	unknown	B	0%
1 Apr 2020	$838M	$508M – $1.5B	$1.0B (+20%)	after a round	–	unknown	B	0%
1 May 2020	$856M	$508M – $1.5B	$1.0B (+17%)	after a round	–	unknown	B	0%
1 Jun 2020	$876M	$508M – $1.5B	$1.0B (+15%)	after a round	–	unknown	B	0%
1 Jul 2020	$895M	$508M – $1.5B	$1.0B (+12%)	after a round	–	unknown	B	0%
1 Aug 2020	$915M	$508M – $1.5B	$1.0B (+10%)	after a round	–	unknown	B	0%
1 Sep 2020	$935M	$508M – $1.5B	$1.0B (+7%)	after a round	–	unknown	B	0%
1 Oct 2020	$956M	$508M – $1.5B	$1.0B (+5%)	after a round	–	unknown	B	0%
1 Nov 2020	$977M	$508M – $1.5B	$1.0B (+3%)	after a round	–	unknown	B	0%
1 Dec 2020	$999M	$508M – $1.5B	$1.0B (+1%)	after a round	–	unknown	B	0%
1 Jan 2021	$1.0B	$491M – $1.5B	$1.0B (0%)	after a round	72	unknown	B	0%
1 Feb 2021	$1.0B	$468M – $1.5B	$1.0B (0%)	after a round	72	unknown	B	0%
1 Mar 2021	$1.0B	$449M – $1.5B	$1.0B (0%)	after a round	72	unknown	C	0%
1 Apr 2021	$1.0B	$429M – $1.5B	$1.0B (0%)	after a round	72	flat	C	0%
1 May 2021	$1.0B	$410M – $1.5B	$1.0B (0%)	after a round	72	flat	C	0%
1 Jun 2021	$1.0B	$391M – $1.5B	$1.0B (0%)	after a round	72	flat	C	0%
1 Jul 2021	$1.0B	$374M – $1.5B	$1.0B (0%)	after a round	72	flat	C	0%
16 Jul 2021	$2.5B	$1.7B – $4.6B	$3.2B (+30%)	after a round	72	flat	B	0%
1 Aug 2021	$2.5B	$1.7B – $4.6B	$3.2B (+28%)	after a round	72	flat	B	0%
1 Sep 2021	$2.6B	$1.7B – $4.6B	$3.2B (+26%)	after a round	72	flat	B	0%
1 Oct 2021	$2.6B	$1.7B – $4.6B	$3.2B (+23%)	after a round	72	flat	B	0%
1 Nov 2021	$2.7B	$1.7B – $4.6B	$3.2B (+20%)	after a round	72	flat	B	0%
1 Dec 2021	$2.7B	$1.7B – $4.6B	$3.2B (+18%)	after a round	72	flat	B	0%
1 Jan 2022	$2.8B	$1.7B – $4.6B	$3.2B (+15%)	after a round	72	flat	B	0%
1 Feb 2022	$3.1B	$2.0B – $5.4B	$3.8B (+21%)	after a round	150	growing	B	0%
1 Mar 2022	$3.2B	$2.0B – $5.4B	$3.8B (+17%)	after a round	150	growing	B	0%
1 Apr 2022	$3.3B	$2.0B – $5.4B	$3.8B (+13%)	after a round	150	growing	B	0%
1 May 2022	$3.5B	$2.0B – $5.4B	$3.8B (+9%)	after a round	150	growing	B	0%
1 Jun 2022	$3.6B	$2.0B – $5.4B	$3.8B (+5%)	after a round	150	growing	B	0%
1 Jul 2022	$3.7B	$2.0B – $5.4B	$3.8B (+2%)	after a round	150	growing	B	0%
1 Aug 2022	$3.8B	$2.1B – $5.4B	$3.8B (0%)	after a round	150	growing	B	0%
1 Sep 2022	$3.8B	$2.1B – $5.4B	$3.8B (0%)	after a round	150	growing	B	0%
1 Oct 2022	$3.8B	$2.1B – $5.4B	$3.8B (0%)	after a round	150	growing	B	0%
1 Nov 2022	$3.8B	$1.7B – $5.4B	$3.8B (0%)	after a round	150	unknown	B	0%
1 Dec 2022	$3.8B	$1.7B – $5.4B	$3.8B (0%)	after a round	150	unknown	B	0%
1 Jan 2023	$4.0B	$2.0B – $5.7B	$4.0B (0%)	after a round	200	up	B	0%
1 Feb 2023	$4.0B	$2.0B – $5.7B	$4.0B (0%)	after a round	200	up	B	0%
1 Mar 2023	$4.0B	$2.0B – $5.7B	$4.0B (0%)	after a round	200	up	B	0%
1 Apr 2023	$4.0B	$2.0B – $5.7B	$4.0B (0%)	after a round	200	up	B	0%
1 May 2023	$4.0B	$2.0B – $5.7B	$4.0B (0%)	after a round	200	up	B	0%
1 Jun 2023	$4.0B	$1.9B – $5.7B	$4.0B (0%)	after a round	200	up	B	0%
1 Jul 2023	$4.0B	$1.9B – $5.7B	$4.0B (0%)	after a round	200	up	B	0%
1 Aug 2023	$4.0B	$1.7B – $5.7B	$4.0B (0%)	after a round	200	up	B	0%
1 Sep 2023	$4.0B	$1.1B – $5.7B	$4.0B (0%)	after a round	200	unknown	C	0%
1 Oct 2023	$4.3B	$1.8B – $6.0B	$4.2B (0%)	after a round	260	up	C	0%
1 Nov 2023	$4.3B	$1.7B – $6.0B	$4.2B (0%)	after a round	260	up	C	0%
1 Dec 2023	$4.3B	$1.7B – $6.0B	$4.2B (0%)	after a round	260	up	C	0%
1 Jan 2024	$4.3B	$1.7B – $6.0B	$4.2B (-1%)	after a round	260	up	C	0%
1 Feb 2024	$4.3B	$1.6B – $6.0B	$4.2B (-1%)	after a round	260	up	C	0%
1 Mar 2024	$4.4B	$2.4B – $6.2B	$4.4B (0%)	after a round	290	growing	B	0%
1 Apr 2024	$4.4B	$2.4B – $6.2B	$4.4B (0%)	after a round	290	growing	B	0%
1 May 2024	$4.4B	$2.4B – $6.2B	$4.4B (0%)	after a round	290	growing	B	0%
1 Jun 2024	$4.4B	$2.4B – $6.2B	$4.4B (0%)	after a round	290	growing	B	0%
1 Jul 2024	$4.4B	$2.4B – $6.2B	$4.4B (0%)	after a round	290	growing	B	0%
26 Jul 2024	$1.9B	$1.2B – $3.7B	$2.4B (+30%)	after a round	290	up	B	0%
1 Aug 2024	$1.9B	$1.2B – $3.7B	$2.4B (+29%)	after a round	300	up	B	0%
1 Sep 2024	$1.9B	$1.2B – $3.7B	$2.4B (+26%)	after a round	300	up	B	0%
1 Oct 2024	$2.0B	$1.2B – $3.7B	$2.4B (+24%)	after a round	300	up	B	0%
1 Nov 2024	$2.0B	$1.2B – $3.7B	$2.5B (+22%)	after a round	310	up	B	0%
1 Dec 2024	$2.1B	$1.2B – $3.7B	$2.5B (+19%)	after a round	310	up	B	0%
1 Jan 2025	$2.1B	$1.2B – $3.7B	$2.5B (+16%)	after a round	310	up	B	0%
1 Feb 2025	$2.2B	$1.2B – $3.7B	$2.5B (+14%)	after a round	310	up	B	0%
1 Mar 2025	$2.2B	$1.2B – $3.7B	$2.5B (+11%)	after a round	310	up	B	0%
1 Apr 2025	$2.3B	$1.2B – $3.7B	$2.5B (+9%)	after a round	310	up	B	0%
1 May 2025	$2.3B	$1.2B – $3.7B	$2.5B (+6%)	after a round	310	flat	B	0%
1 Jun 2025	$2.4B	$1.2B – $3.7B	$2.5B (+4%)	after a round	310	flat	B	0%
1 Jul 2025	$2.4B	$1.2B – $3.7B	$2.5B (+2%)	after a round	310	flat	B	0%
1 Aug 2025	$2.5B	$1.3B – $3.8B	$2.5B (0%)	after a round	328	up	B	0%
1 Sep 2025	$2.5B	$1.2B – $3.8B	$2.5B (0%)	after a round	335	up	B	0%
1 Oct 2025	$2.5B	$1.2B – $3.8B	$2.5B (0%)	after a round	341	up	B	0%
1 Nov 2025	$2.5B	$1.2B – $3.8B	$2.5B (0%)	after a round	341	up	B	0%
1 Dec 2025	$2.5B	$1.2B – $3.8B	$2.5B (0%)	after a round	341	up	B	0%
1 Jan 2026	$2.5B	$1.2B – $3.8B	$2.5B (0%)	after a round	341	up	B	0%
1 Feb 2026	$2.5B	$1.2B – $3.8B	$2.5B (0%)	after a round	341	up	B	0%
1 Mar 2026	$2.5B	$913M – $3.8B	$2.5B (0%)	after a round	341	flat	C	0%
1 Apr 2026	$2.6B	$1.2B – $3.9B	$2.6B (0%)	after a round	393	up	B	0%
1 May 2026	$2.6B	$1.2B – $3.9B	$2.6B (0%)	after a round	393	up	C	0%
1 Jun 2026	$2.6B	$1.2B – $3.9B	$2.6B (0%)	after a round	393	up	C	0%
1 Jul 2026	$2.6B	$1.2B – $3.9B	$2.6B (0%)	after a round	393	up	C	0%
1 Aug 2026	$2.6B	$1.0B – $3.9B	$2.6B (0%)	after a round	393	up	C	0%
1 Sep 2026	$2.6B	$1.0B – $3.9B	$2.6B (0%)	after a round	393	up	C	0%
1 Oct 2026	$2.6B	$1.0B – $4.0B	$2.6B (0%)	after a round	421	up	C	0%
24 Oct 2026	$2.6B	$1.0B – $4.0B	$2.2B (-18%)	after a round	421	up	C	0%

Key facts about Imperative Care

Founded: 2015
Headquarters: Campbell, United States
Employees: about 421 +26% in a year
Total raised: $595M
Funding rounds: 4
Last round: Debt Mar 2026

Imperative Care was founded in 2015 by Amarpreet Sawhney and L. Nelson (Nick) Hopkins.

Imperative Care funding history

Imperative Care has 4 funding rounds on record, from Dec 2019 to Mar 2026, $595M in total. None disclosed a valuation.

Debt 17 Mar 2026no round page
Led by Elevage Medical Technologies, Perceptive Advisors; with Catalio Capital Management, Longaeva Partners LP, Brown Advisory, Ally Bridge Group, Bain Capital Life Sciences.
Sources: imperativecare.com, massdevice.com, vascularnews.com and 1 more
$100M
Series E 25 Jul 2024
Led by Ally Bridge Group; with D1 Capital Partners, Amed Ventures, Bain Capital Life Sciences, Rock Springs Capital, Innovatus Capital Partners, Pura Vida, Catalio Capital Management, HealthCor Family Office, Montreux Growth Partners, INTAI Technology Corp..
Sources: imperativecare.com, mobihealthnews.com, imperativecare.com
$150M
Series D 15 Jul 2021
Led by D1 Capital Partners; with HealthCor Investments LLC, Innovatus Capital Partners, Ally Bridge Group, Bain Capital Life Sciences, Ascension, Delos Capital, Rock Springs Capital, Amed Ventures.
Sources: fiercebiotech.com, baincapital.com, imperativecare.com
$260M
Series C 10 Dec 2019
Led by Ally Bridge Group, Bain Capital Life Sciences; with Ascension, Delos Capital, Rock Springs Capital, Sanzheng Health Investment, Incept LLC.
Sources: finsmes.com, neuronewsinternational.com, evtoday.com and 3 more
$85M

Imperative Care investors

20 investors have backed Imperative Care; Ally Bridge Group, Bain Capital Life Sciences and D1 Capital Partners and 2 more led at least one round.

Bain Capital Life Sciences lead, 4 rounds
D1 Capital Partners lead, 2 rounds
Brown Advisory
HealthCor Family Office
HealthCor Investments LLC
Incept LLC
INTAI Technology Corp.
Longaeva Partners LP

What Imperative Care does

Imperative Care works in medical supply manufacturers, with 14 recorded offerings and customers in healthcare and medical technology.

Imperative Care, Inc., DBA Imperative Care, is a United States medical technology company specialized in stroke and vascular disease care. The company operates as both a service provider and manufacturer, offering product portfolios for stroke, vascular, and robotics applications, and is involved in the development of technologies for thrombectomy care, pulmonary embolism, and recovery support for stroke survivors. Imperative Care also invests in technologies such as artificial intelligence, machine learning, and brain-computer interface systems to support patient recovery and long-term independence.

Description from Veridion's company data.

Products and services

Medical Technology Manufacturing
Stroke Care Product Manufacturing
Vascular Disease Product Manufacturing
Thrombectomy Technology Manufacturing
Robotics-Based Medical Device Manufacturing
AI-Enabled Healthcare Solutions Development
Brain-Computer Interface Technology Development
Tech-Enabled Healthcare Services
Stroke Recovery Support Services
Long-Term Independence Support Services
Clinical Data Validation Services
Physician Partnership Services
Patient Journey Continuum Solutions
Patented Medical Technology Commercialization

Markets

Healthcare
Medical Technology

Technology

Robotics for Thrombectomy
AI Machine Learning
Brain-Computer Interface Technologies

Business model

Business-to-Business
Service Provider
Manufacturing

Questions about Imperative Care

What is Imperative Care worth?

Valuation $2.6B (range $1.0B to $4.0B), as of 24 Oct 2026.

Has Imperative Care raised money?

Imperative Care has 4 funding rounds on record, from Dec 2019 to Mar 2026, $595M in total. None disclosed a valuation.

Who has invested in Imperative Care?

Ally Bridge Group, Bain Capital Life Sciences, D1 Capital Partners, Elevage Medical Technologies, Perceptive Advisors and Rock Springs Capital, and 14 more. Lead investors include Ally Bridge Group, Bain Capital Life Sciences, D1 Capital Partners and Elevage Medical Technologies.

How many people work at Imperative Care?

About 421, up 26% over the last year. Headcount grew from 72 in Jan 2021 to 421 in Sep 2026.

What does Imperative Care do?

Imperative Care works in medical supply manufacturers, with 14 recorded offerings and customers in healthcare and medical technology. Its main offerings are medical technology manufacturing, stroke care product manufacturing and vascular disease product manufacturing.

When was Imperative Care founded, and where is it based?

Imperative Care was founded in 2015 and is based in Campbell, United States. It has about 421 employees, up 26% over the last year.

How we value companies Report an issue